Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

Core Insights - Precigen, Inc. will announce its full year 2025 financial results and provide business updates on March 25, 2026, with a conference call scheduled for 4:30 PM ET [1] Company Overview - Precigen is a commercial-stage biopharmaceutical company focused on innovative precision medicines aimed at improving patient lives, particularly in difficult-to-treat diseases with high unmet needs [1] - The company is committed to advancing scientific breakthroughs from proof-of-concept through commercialization, developing a robust pipeline in immuno-oncology, autoimmune disorders, and infectious diseases [1] Upcoming Events - The conference call for discussing the financial results will be accessible via specific phone numbers for North America and international participants, with a recommendation to dial in 10-15 minutes early [1]